Addyi half-life and pharmacokinetics
Half-life describes how long it takes plasma concentration of Flibanserin to drop by half after a dose. It is the most useful single number for understanding why Addyi (Flibanserin) is dosed the way it is — once daily, on demand, or some other schedule. The 100mg strengths and tablet formulation tune the curve.
Why half-life matters
Flibanserin reaches peak plasma levels some hours after dosing, then decays. Short half-life agents are out of the system quickly and well-suited to event-driven dosing. Long half-life agents allow once-daily continuous coverage but accumulate over the first few days until reaching steady state. Sexual desire is modulated by complex central nervous system pathways involving serotonin (generally inhibitory) and dopamine and norepinephrine (generally excitatory).
Practical dose-pacing
According to the prescribing information for Flibanserin, the dosing interval reflects the half-life and the desired duration of effect. Re-dosing inside the half-life window stacks plasma concentration without proportional benefit; spacing doses correctly keeps the steady-state where it is expected. The 100mg options exist to allow personalised exposure within this framework.
Frequently asked questions
How long does Addyi stay in your system? ▾
Most active drug clears within four to five half-lives. For Flibanserin the exact half-life is in the prescribing information, but residual measurable drug may persist longer than the subjective effect at 100mg.
Can Addyi accumulate over time? ▾
Daily dosing of any drug accumulates until plasma concentrations reach steady state, typically within four to five half-lives. After that, Addyi stays at predictable levels as long as the 100mg dose is unchanged. This is by design and is not the same as harmful accumulation.
More on Addyi
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.